Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 203

1.

Active surveillance of adverse events following immunization against pandemic influenza A (H1N1) in Korea.

Choe YJ, Cho H, Song KM, Kim JH, Han OP, Kwon YH, Bae GR, Lee HJ, Lee JK.

Jpn J Infect Dis. 2011;64(4):297-303.

PMID:
21788704
[PubMed - indexed for MEDLINE]
Free Article
2.

Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations.

Banzhoff A, Haertel S, Praus M.

Hum Vaccin. 2011 May;7(5):539-48. Epub 2011 May 1.

PMID:
21422814
[PubMed - indexed for MEDLINE]
Free Article
3.

Comparison of the adverse events associated with MF59-adjuvanted and non-adjuvanted H1N1 vaccines in healthy young male Korean soldiers.

Hwang SM, Kim HL, Min KW, Kim M, Lim JS, Choi JM, Chun BC, Kim MJ, Lee SM, Kim SY, Jeon HH.

Jpn J Infect Dis. 2012;65(3):193-7.

PMID:
22627298
[PubMed - indexed for MEDLINE]
Free Article
5.

[Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].

Ertek M, Sevencan F, Kalaycıoğlu H, Gözalan A, Simşek C, Culha G, Dorman V, Ozlü A, Arıkan F, Aktaş D, Akın L, Korukluoğlu G, Sevindi DF.

Mikrobiyol Bul. 2011 Oct;45(4):684-96. Turkish.

PMID:
22090299
[PubMed - indexed for MEDLINE]
6.

Long-lasting immunogenicity and safety of a 2009 pandemic influenza A(H1N1) MF59-adjuvanted vaccine when co-administered with a 2009-2010 seasonal influenza vaccine in young patients with type 1 diabetes mellitus.

Zuccotti GV, Pariani E, Scaramuzza A, Santoro L, Giani E, Macedoni M, Gazzarri A, Anselmi G, Amendola A, Zanetti A.

Diabet Med. 2011 Dec;28(12):1530-6. doi: 10.1111/j.1464-5491.2011.03449.x.

PMID:
21916971
[PubMed - indexed for MEDLINE]
7.

Effectiveness of vaccine against pandemic influenza A/H1N1 among people with underlying chronic diseases: cohort study, Denmark, 2009-10.

Emborg HD, Krause TG, Hviid A, Simonsen J, Mølbak K.

BMJ. 2011 Jan 25;344:d7901. doi: 10.1136/bmj.d7901.

PMID:
22277542
[PubMed - indexed for MEDLINE]
Free Article
8.

Safety of influenza A (H1N1) 2009 monovalent vaccines - United States, October 1-November 24, 2009.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2009 Dec 11;58(48):1351-6.

PMID:
20010511
[PubMed - indexed for MEDLINE]
Free Article
9.

Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months.

Carmona A, Omeñaca F, Tejedor JC, Merino JM, Vaman T, Dieussaert I, Gillard P, Arístegui J.

Vaccine. 2010 Aug 16;28(36):5837-44. doi: 10.1016/j.vaccine.2010.06.065. Epub 2010 Jun 29.

PMID:
20600478
[PubMed - indexed for MEDLINE]
10.

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009.

Skowronski DM, Janjua NZ, De Serres G, Hottes TS, Dickinson JA, Crowcroft N, Kwindt TL, Tang P, Charest H, Fonseca K, Gubbay JB, Bastien N, Li Y, Petric M.

BMJ. 2011 Feb 3;342:c7297. doi: 10.1136/bmj.c7297.

PMID:
21292718
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Italian post-marketing surveillance for adverse event reports after MF59-adjuvanted H1N1v vaccination.

Parretta E, Ianniello B, Ferrazin F, Rossi F, Capuano A.

Vaccine. 2011 May 9;29(20):3708-13. doi: 10.1016/j.vaccine.2011.02.097. Epub 2011 Mar 12.

PMID:
21406267
[PubMed - indexed for MEDLINE]
12.

Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010.

Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, Martin D, DeStefano F.

Vaccine. 2010 Oct 21;28(45):7248-55. doi: 10.1016/j.vaccine.2010.09.021. Epub 2010 Sep 16.

PMID:
20850534
[PubMed - indexed for MEDLINE]
13.

Spontaneous reporting of adverse events following immunisation against pandemic influenza in Denmark November 2009-March 2010.

Folkenberg M, Callréus T, Svanström H, Valentiner-Branth P, Hviid A.

Vaccine. 2011 Feb 1;29(6):1180-4. doi: 10.1016/j.vaccine.2010.12.008. Epub 2010 Dec 18.

PMID:
21172382
[PubMed - indexed for MEDLINE]
14.

An early (3-6 weeks) active surveillance study to assess the safety of pandemic influenza vaccine Focetria in a province of Emilia-Romagna region, Italy - part one.

Candela S, Pergolizzi S, Ragni P, Cavuto S, Nobilio L, Di Mario S, Dragosevic V, Groth N, Magrini N; SaFoH1N1 working group.

Vaccine. 2013 Feb 27;31(10):1431-7. doi: 10.1016/j.vaccine.2012.06.030. Epub 2012 Jul 2.

PMID:
22766247
[PubMed - indexed for MEDLINE]
15.

Pandemic 2009 H1N1 influenza virus vaccination in lung transplant recipients: coverage, safety and clinical effectiveness in the Zurich cohort.

Schuurmans MM, Tini GM, Dalar L, Fretz G, Benden C, Boehler A.

J Heart Lung Transplant. 2011 Jun;30(6):685-90. doi: 10.1016/j.healun.2011.01.707. Epub 2011 Mar 27. Erratum in: J Heart Lung Transplant. 2011 Oct;30(10):1206.

PMID:
21444211
[PubMed - indexed for MEDLINE]
16.

[Variability in the reporting of adverse reactions to the pandemic and seasonal influenza vaccine: seasons 2009-2010 and 2010-2011. Valencian community, Spain].

Alguacil Ramos AM, Lluch Rodrigo JA, Portero Alonso A, Martín Ivorra R, Pastor Villalba E.

Rev Esp Salud Publica. 2012 May-Jun;86(3):241-51. Spanish.

PMID:
22991081
[PubMed - indexed for MEDLINE]
Free Article
17.

Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial.

Vajo Z, Tamas F, Sinka L, Jankovics I.

Lancet. 2010 Jan 2;375(9708):49-55. doi: 10.1016/S0140-6736(09)62039-0. Epub 2009 Dec 15.

PMID:
20018367
[PubMed - indexed for MEDLINE]
18.

Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial.

Liang XF, Wang HQ, Wang JZ, Fang HH, Wu J, Zhu FC, Li RC, Xia SL, Zhao YL, Li FJ, Yan SH, Yin WD, An K, Feng DJ, Cui XL, Qi FC, Ju CJ, Zhang YH, Guo ZJ, Chen PY, Chen Z, Yan KM, Wang Y.

Lancet. 2010 Jan 2;375(9708):56-66. doi: 10.1016/S0140-6736(09)62003-1. Epub 2009 Dec 15. Erratum in: Lancet. 2010 May 15;375(9727):1694.

PMID:
20018364
[PubMed - indexed for MEDLINE]
19.

Safety of pandemic H1N1 vaccines in children and adolescents.

Wijnans L, de Bie S, Dieleman J, Bonhoeffer J, Sturkenboom M.

Vaccine. 2011 Oct 6;29(43):7559-71. doi: 10.1016/j.vaccine.2011.08.016. Epub 2011 Aug 5. Review.

PMID:
21821086
[PubMed - indexed for MEDLINE]
20.

H1N1 and seasonal influenza vaccine safety in the vaccine safety datalink project.

Lee GM, Greene SK, Weintraub ES, Baggs J, Kulldorff M, Fireman BH, Baxter R, Jacobsen SJ, Irving S, Daley MF, Yin R, Naleway A, Nordin JD, Li L, McCarthy N, Vellozzi C, Destefano F, Lieu TA; Vaccine Safety Datalink Project.

Am J Prev Med. 2011 Aug;41(2):121-8. doi: 10.1016/j.amepre.2011.04.004.

PMID:
21767718
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk